ASweetLife Team, Author at ASweetLife

Breastfeeding May Lower a Woman’s Risk of Developing Metabolic Syndrome

Breastfeeding her child may lower a woman's risk of developing Metabolic Syndrome, a condition linked to heart disease and diabetes in women, according to a Kaiser Permanente study that was published online by PR Newswire, and will appear in the February issue of Diabetes.

Phase III Trials Show Roche’s Type 2 Drug Better Than Januvia

The Swiss -based pharmaceuticals and diagnostics company Roche Holding AG announced headline results from the second and third of eight T-emerge Phase III studies for taspoglutide. Taspoglutide is the first once-weekly human glucagon-like peptide-1 (GLP-1) analogue being developed to address the important unmet needs of patients with type 2 diabetes....

Sunday Brunch: Asparagus and Smoked Salmon Frittata

Springtime is asparagus time in most parts of the world, so it's a perfect moment to make an asparagus and smoked salmon frittata recipe, which I've adapted from Tom Valenti's terrific new cookbook, You Don't Have to Be Diabetic To Love This Cookbook.

Jay Cutler May Give Insulin Pump Another Chance

Jay Cutler said he'll look into wearing an insulin pump during the offseason to manage his type 1 diabetes. According to the Chicago Sun-Times Cutler tried outfitting himself with one in Denver a short time after being diagnosed but had difficulty keeping it on. "I tried it out probably a month after I was diagnosed, and we went into camp wearing it, the offseason workouts,'' he said...

Old Drug May Hold New Hope

A drug commonly used to treat non-Hodgkin's lymphoma and rheumatoid arthritis now also shows some promise in helping patients newly diagnosed with type 1 diabetes. The drug, rituximab (Rituxan) helped patients continue to produce some of their own insulin...

Success Rate of Islet Cells Transplants May Improve With New Treatment

TikoMed AB, a Swedish biotechnology company focused on development and commercialization of innovative treatments for immune diseases and cell therapies, announced that IBsolvMIR® has been granted orphan drug designation for the prevention of graft rejection of pancreatic islet transplantation by the U.S. Food and Drug Administration (FDA)...

Surgery Recognized as Legitimate Treatment for Type 2 Diabetes

A first-of-its-kind consensus statement on diabetes surgery was published online yesterday in the Annals of Surgery. The statement was issued following the first international consensus conference, Diabetes Surgery Summit (DSS), where an international group of more than 50 scientific and medical experts agreed on a set of evidence-based guidelines and definitions that are meant to guide the use...

Januvia (Sitagliptin) has been approved by the European Commission

According to Diabetes UK the European Commission has approved Sitagliptin ,known as Januvia, as an add-on to insulin (with or without metformin) for people with type 2 diabetes. Most type 2 diabetics can control their condition with a combination of diet, physical activity and conventional medication. Januvia was approved by the FDA in 2006...

Jay Cutler Doesn’t Have Trouble Seeing At Night

Jay Cutler has had a bad run so far this season. He is 0-3 in nationally televised night games, throwing 11 of his NFL-high 17 interceptions. There has been speculation that this may be sight related but Ron Turner, the Bears offensive coordinator, doesn't think this is the case.

Sirona Biochem Corp. Says New Results Show SGLT2 Sugar Blockers Could Help Fight Diabetes

In a press release dated November 17, Sirona Biochem Corp. announced that results of their latest clinical trials showed the SGLT2 inhibitor dapagliflozin lowered levels of HbA1c blood sugar significantly more than the placebo, and that it was safe and well tolerated with no serious treatment-related adverse events...